Key Treatment and Outcome Data for Patients Undergoing Therapy with Assistance of Ureteral Access Sheaths (UASs)

Drs Semins and Bechis discuss the utility and benefits of ureteral access sheaths, emphasizing their role in optimizing visualization, reducing intra-renal pressure, and potentially mitigating postoperative complications, while also noting the importance of size selection and highlighting emerging technologies that measure pressures and manage thermal injury.

EP: 1.Overview of the Incidence, Diagnosis, and Treatment of Urinary Stones

EP: 2.The Evolving Role of Ureteroscopy in the Treatment of Urinary Stones

EP: 3.Overview of Intrarenal Pressure (IRP)

EP: 4.Potential Complications Seen in Patients With Elevated IRP

EP: 5.Strategies for Reducing Risk of Elevated IRP

Now Viewing

EP: 6.Key Treatment and Outcome Data for Patients Undergoing Therapy with Assistance of Ureteral Access Sheaths (UASs)

EP: 7.Factors for Consideration When Employing UASs In Patients With Urinary Stones

EP: 8.Methods for Continuous IRP Monitoring in Patients With Urinary Stones

EP: 9.Future Perspectives in the Treatment of Patients With Urinary Stones

Related Videos

Related Content

Advertisement

November 13th 2024

FDA grants de novo clearance to Stone Clear device

Hannah Clarke

"The Stone Clear device provides patients with a non-invasive option to reduce their residual fragment stone burden in the clinic environment while being fully awake," says James E. Lingeman, MD.

February 17th 2022

Why kidney stones will become more prevalent over time

Urology Times staff

“The prevalence of kidney stones has increased over 80% over the last 30 years, and the epidemiology has changed such that it's beginning at a younger age now,” says Gregory Tasian, MD, MSc, MSCE.

August 29th 2024

Ultrasonic propulsion for clearance of residual kidney stone fragments reduces relapse

Hannah Clarke

In total, 8 of 40 patients who underwent ultrasonic propulsion experienced relapse, compared with 21 of 42 patients who underwent observation.

September 9th 2021

Dr. Krambeck investigates efficacy of Trilogy and ShockPulse-SE lithotripters

Urology Times staff

“You have tradeoffs with every device that you use,” says Amy E. Krambeck, MD.

August 24th 2024

Trial launches of gene editing therapy for primary hyperoxaluria type 1

Hannah Clarke

In total, the trial plans to enroll 7 patients with PH1 through a single center in China.

August 21st 2024

Data suggest Break Wave lithotripsy is safe, effective for urolithiasis

Hannah Clarke

Any stone fragmentation was achieved in 88% of patients.

Related Content

Advertisement

November 13th 2024

FDA grants de novo clearance to Stone Clear device

Hannah Clarke

"The Stone Clear device provides patients with a non-invasive option to reduce their residual fragment stone burden in the clinic environment while being fully awake," says James E. Lingeman, MD.

February 17th 2022

Why kidney stones will become more prevalent over time

Urology Times staff

“The prevalence of kidney stones has increased over 80% over the last 30 years, and the epidemiology has changed such that it's beginning at a younger age now,” says Gregory Tasian, MD, MSc, MSCE.

August 29th 2024

Ultrasonic propulsion for clearance of residual kidney stone fragments reduces relapse

Hannah Clarke

In total, 8 of 40 patients who underwent ultrasonic propulsion experienced relapse, compared with 21 of 42 patients who underwent observation.

September 9th 2021

Dr. Krambeck investigates efficacy of Trilogy and ShockPulse-SE lithotripters

Urology Times staff

“You have tradeoffs with every device that you use,” says Amy E. Krambeck, MD.

August 24th 2024

Trial launches of gene editing therapy for primary hyperoxaluria type 1

Hannah Clarke

In total, the trial plans to enroll 7 patients with PH1 through a single center in China.

August 21st 2024

Data suggest Break Wave lithotripsy is safe, effective for urolithiasis

Hannah Clarke

Any stone fragmentation was achieved in 88% of patients.